Literature DB >> 8353425

Dystrophin and related proteins.

J M Tinsley1, D J Blake, M Pearce, A E Knight, J Kendrick-Jones, K E Davies.   

Abstract

During the past year significant progress has been made in understanding how dystrophin deficiency leads to muscle cell necrosis in Duchenne muscular dystrophy and Becker muscular dystrophy. Dystrophin interacts with a glycoprotein complex spanning the muscle sarcolemma, effectively linking the actin cytoskeleton to the extracellular matrix. The carboxyl terminus of dystrophin is required for glycoprotein binding. Interestingly, at least three mRNAs transcribed from the distal end of the DMD gene in tissues other than muscle have been shown to encode this domain. Deficiency of a second component of the dystrophin-associated glycoprotein complex has been shown to occur in another muscle-wasting disorder, severe childhood autosomal recessive muscular dystrophy. Sequence analysis of the entire cDNA for the autosomal dystrophin-related protein utrophin has shown that dystrophin and utrophin are closely related. Furthermore, both of these proteins have been shown to bind to the same or a similar glycoprotein complex in muscle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353425     DOI: 10.1016/0959-437x(93)90124-8

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  11 in total

Review 1.  [Molecular pathogenesis of muscular diseases].

Authors:  K Ohlendieck
Journal:  Naturwissenschaften       Date:  1996-12

2.  Gene deletions in spinal muscular atrophy.

Authors:  N R Rodrigues; N Owen; K Talbot; S Patel; F Muntoni; J Ignatius; V Dubowitz; K E Davies
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

Review 3.  Increasing complexity of the dystrophin-associated protein complex.

Authors:  J M Tinsley; D J Blake; R A Zuellig; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

4.  Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth.

Authors:  Diane L Sherman; Lai Man N Wu; Matthew Grove; C Stewart Gillespie; Peter J Brophy
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

Review 5.  Therapeutics in duchenne muscular dystrophy.

Authors:  Jonathan B Strober
Journal:  NeuroRx       Date:  2006-04

6.  Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site.

Authors:  Maria Grazia D'Angelo; Maria Luisa Lorusso; Federica Civati; Giacomo Pietro Comi; Francesca Magri; Roberto Del Bo; Michela Guglieri; Massimo Molteni; Anna Carla Turconi; Nereo Bresolin
Journal:  Pediatr Neurol       Date:  2011-11       Impact factor: 3.372

7.  Evaluation of neural damage in Duchenne muscular dystrophy patients.

Authors:  Ekram Abdel Salam; Iman Ehsan Abdel-Meguid; Rania Shatla; Soheir Korraa
Journal:  Acta Myol       Date:  2014-05

Review 8.  Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype.

Authors:  Takeshi Tsuda; Kristi K Fitzgerald
Journal:  J Cardiovasc Dev Dis       Date:  2017-09-08

9.  Community Structure Analysis of Gene Interaction Networks in Duchenne Muscular Dystrophy.

Authors:  Tejaswini Narayanan; Shankar Subramaniam
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress.

Authors:  P P Pandolfi; F Sonati; R Rivi; P Mason; F Grosveld; L Luzzatto
Journal:  EMBO J       Date:  1995-11-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.